Shionogi & Co Ltd SGIOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SGIOF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $53.50
- Day Range
- $49.60–49.60
- 52-Week Range
- $40.46–53.50
- Bid/Ask
- $43.84 / $48.49
- Market Cap
- $14.21 Bil
- Volume/Avg
- 514 / 325
Key Statistics
- Price/Earnings (Normalized)
- 12.50
- Price/Sales
- 4.80
- Dividend Yield (Trailing)
- 2.02%
- Dividend Yield (Forward)
- 0.01%
- Total Yield
- 4.51%
Company Profile
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 6,204
- Website
- http://www.shionogi.co.jp
Comparables
Valuation
|
Metric
|
SGIOF
|
INVA
|
4569
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.50 | 8.95 | 26.54 |
Price/Book Value | 1.70 | 1.38 | 0.81 |
Price/Sales | 4.80 | 4.11 | 0.86 |
Price/Cash Flow | 14.78 | 7.69 | 11.09 |
Price/Earnings
SGIOF
INVA
4569
Financial Strength
|
Metric
|
SGIOF
|
INVA
|
4569
|
|---|---|---|---|
Quick Ratio | 5.74 | 7.28 | 1.33 |
Current Ratio | 6.57 | 9.03 | 2.53 |
Interest Coverage | 18.41 | 10.31 | 94.05 |
Quick Ratio
SGIOF
INVA
4569
Profitability
|
Metric
|
SGIOF
|
INVA
|
4569
|
|---|---|---|---|
Return on Assets (Normalized) | 12.14% | 14.79% | 3.16% |
Return on Equity (Normalized) | 14.21% | 29.29% | 4.40% |
Return on Invested Capital (Normalized) | 10.70% | 16.71% | 3.57% |
Return on Assets
SGIOF
INVA
4569
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Tfqylyxyz | Dkzs | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Xsffhdcwz | Sfshljl | $68.1 Bil | |
HLN
| Haleon PLC ADR | Mzwsttzvy | Dpvd | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Prkkkbpc | Kzmr | $14.3 Bil | |
VTRS
| Viatris Inc | Mwrcwxxv | Hsn | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kwqjldtd | Lxk | $12.0 Bil | |
CTLT
| Catalent Inc | Wjnmhkqgy | Hqdgr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Fdvcsnc | Yts | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Dppfdmk | Xxjv | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Nltmhgc | Rlpszm | $3.4 Bil |